These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 21319062

  • 1. Efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) performed in a patient with primary biliary cirrhosis with severe recurrent hepatic encephalopathy due to splenorenal shunt.
    Takashimizu S, Watanabe N, Kojima S, Kagawa T, Mine T, Myojin K, Koizumi J.
    Tokai J Exp Clin Med; 2007 Jul 20; 32(2):70-4. PubMed ID: 21319062
    [Abstract] [Full Text] [Related]

  • 2. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome.
    Kumamoto M, Toyonaga A, Inoue H, Miyakoda K, Morita Y, Emori K, Sakamoto Y, Oho K, Sata M.
    J Gastroenterol Hepatol; 2010 Jun 20; 25(6):1129-35. PubMed ID: 20594229
    [Abstract] [Full Text] [Related]

  • 3. Hepatic encephalopathy from dual splenorenal shunts treated with balloon-occluded retrograde transvenous obliteration by using a double-balloon technique.
    Matake K, Tajima T, Yoshimitsu K, Irie H, Aibe H, Nishie A, Asayama Y, Honda H.
    J Vasc Interv Radiol; 2007 Nov 20; 18(11):1436-40. PubMed ID: 18003996
    [Abstract] [Full Text] [Related]

  • 4. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension.
    Miyamoto Y, Oho K, Kumamoto M, Toyonaga A, Sata M.
    J Gastroenterol Hepatol; 2003 Aug 20; 18(8):934-42. PubMed ID: 12859723
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis.
    Kato T, Uematsu T, Nishigaki Y, Sugihara J, Tomita E, Moriwaki H.
    Intern Med; 2001 Aug 20; 40(8):688-91. PubMed ID: 11518103
    [Abstract] [Full Text] [Related]

  • 6. [Successful balloon-occluded retrograde transvenous obliteration (B-RTO) in a case of symptomatic epilepsy with hepatic encephalopathy due to non-cirrhotic porto-systemic shunt].
    Shibata A, Hayashi S, Noguchi M.
    Rinsho Shinkeigaku; 2005 May 20; 45(5):341-5. PubMed ID: 15960169
    [Abstract] [Full Text] [Related]

  • 7. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy.
    Ibukuro K, Sugihara T, Tanaka R, Fukuda H, Abe S, Tobe K, Tateishi R, Tagawa K.
    J Vasc Interv Radiol; 2007 Jan 20; 18(1 Pt 1):121-5. PubMed ID: 17296712
    [Abstract] [Full Text] [Related]

  • 8. Portal-systemic shunt between the inferior mesenteric vein and inferior vena cava in a patient with hepatic encephalopathy: successful occlusion by balloon-occluded retrograde transvenous obliteration.
    Kakizawa H, Toyota N, Hieda M, Ishikawa M, Tanitame K, Tani C, Okazaki A, Takaki S, Aikata H, Chayama K, Awai K.
    Hiroshima J Med Sci; 2011 Mar 20; 60(1):15-9. PubMed ID: 21675043
    [Abstract] [Full Text] [Related]

  • 9. Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.
    Inoue H, Emori K, Toyonaga A, Oho K, Kumamoto M, Haruta T, Mitsuyama K, Tsuruta O, Sata M.
    Kurume Med J; 2014 Mar 20; 61(1-2):1-8. PubMed ID: 25420513
    [Abstract] [Full Text] [Related]

  • 10. Successful portal-systemic shunt occlusion with balloon-occluded retrograde transvenous obliteration for portosystemic encephalopathy without liver cirrhosis.
    Tanaka O, Ishihara K, Oyamada H, Harusato A, Yamaguchi T, Ozawa M, Nakano K, Yamagami T, Nishimura T.
    J Vasc Interv Radiol; 2006 Dec 20; 17(12):1951-5. PubMed ID: 17185692
    [Abstract] [Full Text] [Related]

  • 11. [A case of portal-systemic shunt-through inferior mesenteric vein and right internal iliac vein-encephalopathy cured by balloon-occluded retrograde transvenous obliteration].
    Shimizu K, Nakashima M, Fujimoto M, Tsuruta S, Morita S, Furukawa R, Mori M.
    Nihon Shokakibyo Gakkai Zasshi; 2009 Dec 20; 106(12):1764-9. PubMed ID: 19966519
    [Abstract] [Full Text] [Related]

  • 12. Control of solitary gastric fundal varices and portosystemic encephalopathy accompanying liver cirrhosis by balloon-occluded retrograde transvenous obliteration (B-RTO): a case report.
    Ohmoto K, Miyake I, Tsuduki M, Ohno S, Yamamoto S.
    Hepatogastroenterology; 1999 Dec 20; 46(26):1249-52. PubMed ID: 10370701
    [Abstract] [Full Text] [Related]

  • 13. Development of a new coaxial balloon catheter system for balloon-occluded retrograde transvenous obliteration (B-RTO).
    Tanoue S, Kiyosue H, Matsumoto S, Hori Y, Okahara M, Kashiwagi J, Mori H.
    Cardiovasc Intervent Radiol; 2006 Dec 20; 29(6):991-6. PubMed ID: 16736100
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy.
    Fukuda T, Hirota S, Sugimura K.
    J Vasc Interv Radiol; 2001 Mar 20; 12(3):327-36. PubMed ID: 11287510
    [Abstract] [Full Text] [Related]

  • 15. Balloon-occluded retrograde transvenous obliteration of varices: focusing on the portal hemodynamics and the recent techniques.
    Hirota S, Kobayashi K, Kako Y, Takaki H, Yamakado K.
    Hepatol Int; 2018 Feb 20; 12(Suppl 1):102-111. PubMed ID: 28875380
    [Abstract] [Full Text] [Related]

  • 16. Balloon-occlusion Retrograde Transvenous Obliteration Using Gadoteridol As an Alternative Contrast Agent in a Patient with Iodine Allergy.
    Iwasa T, Adachi S, Oyama Y, Suzuki Y, Mabuchi M, Nakamura H, Shimazaki M, Nishiwaki S, Iwashita T, Shimizu M.
    Intern Med; 2024 Apr 15; 63(8):1099-1103. PubMed ID: 37690844
    [Abstract] [Full Text] [Related]

  • 17. Portal hemodynamics and clinical outcomes of patients with gastric varices after balloon-occluded retrograde transvenous obliteration.
    Kasuga A, Mizumoto H, Matsutani S, Kobayashi A, Endo T, Ando T, Yukisawa S, Maruyama H, Yokosuka O.
    J Hepatobiliary Pancreat Sci; 2010 Nov 15; 17(6):898-903. PubMed ID: 20461439
    [Abstract] [Full Text] [Related]

  • 18. [Intrahepatic portosystemic venous shunt via right renal vein successfully treated with balloon-occluded retrograde transvenous obliteration].
    Hashiguchi K, Yamasaki K, Ichikawa T, Takeshima F, Nakao K.
    Nihon Shokakibyo Gakkai Zasshi; 2011 Oct 15; 108(10):1726-34. PubMed ID: 21971147
    [Abstract] [Full Text] [Related]

  • 19. [Balloon-occluded retrograde transvenous obliteration (B-RTO) for gastric varices: therapeutic results and problems].
    Kiyosue H, Matsumoto S, Onishi R, Okahara M, Hori Y, Yamada Y, Dono S, Mori H.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Jan 15; 59(1):12-9. PubMed ID: 10067311
    [Abstract] [Full Text] [Related]

  • 20. [Balloon-occluded retrograde transvenous obliteration (B-RTO) for portal hypertension].
    Hirota S, Fukuda T, Matsumoto S, Sugimoto K, Isaki K, Yoshikawa T, Akasaka Y, Sugimura K.
    Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Jun 15; 60(7):361-7. PubMed ID: 10921294
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.